Law360 (February 23, 2018, 8:05 PM EST) — A Texas federal judge on Thursday denied a bid for a new trial after a jury in January held that a medical company did not infringe the asserted claims of a health supplement patent, holding that the patent’s owner failed to introduce sufficient evidence to …
